Glucocorticoid replacement therapies: past, present and future.

Area of Science:

• Endocrinology
• Adrenal Gland Biology
• Hypothalamic-Pituitary-Adrenal Axis Physiology

Background:

• Adrenal insufficiency, first described in 1855, involves dysfunction of the adrenal glands.
• The hypothalamic-pituitary-adrenal axis regulates the body's response to stress via glucocorticoids.
• Current glucocorticoid replacement therapy has remained largely unchanged for decades, despite recognized limitations.

Purpose of the Study:

• To review the historical evolution of glucocorticoid replacement therapy.
• To analyze current practices and their associated challenges in managing adrenal insufficiency.
• To explore emerging strategies, including stem cell therapy, for future treatment.

Main Methods:

• Literature review of historical and contemporary research on glucocorticoid replacement.
• Analysis of clinical outcomes and morbidity associated with different therapeutic approaches.
• Exploration of novel therapeutic avenues, such as regenerative medicine.

Main Results:

• Glucocorticoid replacement therapy has a long history, evolving from early 20th-century practices.
• Despite advancements in understanding adrenal function, treatment paradigms have seen minimal innovation.
• Current therapies are associated with significant morbidity and mortality, highlighting the need for improvement.

Conclusions:

• There is a critical need to update glucocorticoid replacement strategies for adrenal insufficiency.
• Future treatments may involve innovative approaches like stem cell therapy to improve patient outcomes.
• Further research is essential to overcome the limitations of current adrenal insufficiency management.